发明名称 Nucleic acid preparation compositions and methods
摘要 Provided herein are methods and compositions to extract and enrich by, physical separation or amplification, relatively short nucleic acids from a nucleic acid composition containing a high background of longer nucleic acids (e.g., host or maternal nucleic acids; genomic nucleic acid and the like).
申请公布号 US9580741(B2) 申请公布日期 2017.02.28
申请号 US201414296732 申请日期 2014.06.05
申请人 Sequenom, Inc. 发明人 Wisniewski Michele Elizabeth;Kwong William Hang;Mohsenian Firouz;Ding Jian-Hua
分类号 C12Q1/68;C12N15/10 主分类号 C12Q1/68
代理机构 Grant IP, Inc. 代理人 Grant IP, Inc.
主权项 1. A method for detecting the presence or absence of fetal nucleic acid in a substantially cell-free biological composition, which comprises: (a) contacting cell-free nucleic acid from the substantially cell-free biological composition with a solid phase under association conditions, wherein: (i) the nucleic acid of the biological composition comprises relatively short nucleic acid and relatively long nucleic acid,(ii) The relatively short nucleic acid may comprise fetal nucleic acid,(iii) the relatively short nucleic acid is 300 base pairs or less,(iv) the relatively long nucleic acid is larger than 300 base pairs, and(v) the association conditions do not include polyethylene glycol; whereby the relatively short nucleic acid and the relatively long nucleic acid are associated with the solid phase; (b) introducing the solid phase after (a) to dissociation conditions that comprise a volume exclusion agent and a salt, wherein: (i) the salt is not a chaotropic salt, and(ii) the relatively short nucleic acid preferentially dissociates from the solid phase under the dissociation conditions as compared to the relatively long nucleic acid, thereby yielding dissociated nucleic acid; (c) separating the dissociated nucleic acid from the solid phase, whereby the fetal nucleic acid, when present, is enriched in the dissociated nucleic acid relative to in the cell-free nucleic acid from the substantially cell-free biological composition, thereby yielding a sample comprising enriched fetal nucleic acid, when present; and (d) detecting the presence or absence of fetal nucleic acid in the sample comprising enriched fetal nucleic acid, when present, thereby detecting the presence or absence of fetal nucleic acid in the substantially cell-free biological composition.
地址 San Diego CA US